Tech Company Financing Transactions
Huma Funding Round
AstraZeneca, Hitachi Ventures and Leaps by Bayer participated in a $80 million Series D funding round for Huma. The financing round was announced by the company on 7/16/2024.
Transaction Overview
Company Name
Announced On
7/16/2024
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Series D
Proceeds Purpose
The company intends to use the funds to expand operations and its business reach.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
Millbank Tower 21-24 Millbank
London, SW1P 4QP
UK
London, SW1P 4QP
UK
Phone
Undisclosed
Website
Email Address
Overview
Huma began its journey in 2011, when the company was founded in London. Since then, Huma has grown to become a global healthcare company, spanning across multiple geographies and operating across four continents. We are not constrained by geography -- for many roles at Huma, our brilliant team can choose to work wherever they have an Internet connection.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dan Vahdat
Browse more venture capital transactions:
Prev: 7/16/2024: Infinitum venture capital transaction
Next: 7/16/2024: Naked Energy venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs